BRPI0513455A - formulação para mascaramento de sabor compreendendo o fármaco em uma forma de dissolução retardada e/ou ciclodextrina em uma forma de dissolução melhorada - Google Patents

formulação para mascaramento de sabor compreendendo o fármaco em uma forma de dissolução retardada e/ou ciclodextrina em uma forma de dissolução melhorada

Info

Publication number
BRPI0513455A
BRPI0513455A BRPI0513455-2A BRPI0513455A BRPI0513455A BR PI0513455 A BRPI0513455 A BR PI0513455A BR PI0513455 A BRPI0513455 A BR PI0513455A BR PI0513455 A BRPI0513455 A BR PI0513455A
Authority
BR
Brazil
Prior art keywords
cyclodextrin
dissolution form
drug
flavor masking
delayed
Prior art date
Application number
BRPI0513455-2A
Other languages
English (en)
Inventor
Jennifer Hsing-Chung Chu
Dwayne Thomas Friesen
David Keith Lyon
Rodney James Ketner
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0513455A publication Critical patent/BRPI0513455A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Abstract

FORMULAçãO PARA MASCARAMENTO DE SABOR COMPREENDENDO O FáRMACO EM UMA FORMA DE DISSOLUçãO RETARDADA E/OU CICLODEXTRINA EM UMA FORMA DE DISSOLUçãO MELHORADA Mascaramento de gosto melhorado de composições farmacêuticas de drogas de sabor desagradável e ciclodextrina é conseguido pela formação de uma mistura de droga e ciclodextrina em que a taxa de dissolução da droga tenha sido retardada, ou a taxa de dissolução de ciclodextrina tenha sido intensificada, ou ambos.
BRPI0513455-2A 2004-07-22 2005-07-11 formulação para mascaramento de sabor compreendendo o fármaco em uma forma de dissolução retardada e/ou ciclodextrina em uma forma de dissolução melhorada BRPI0513455A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59080304P 2004-07-22 2004-07-22
PCT/IB2005/002231 WO2006011051A1 (en) 2004-07-22 2005-07-11 Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form

Publications (1)

Publication Number Publication Date
BRPI0513455A true BRPI0513455A (pt) 2008-05-06

Family

ID=35094144

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513455-2A BRPI0513455A (pt) 2004-07-22 2005-07-11 formulação para mascaramento de sabor compreendendo o fármaco em uma forma de dissolução retardada e/ou ciclodextrina em uma forma de dissolução melhorada

Country Status (9)

Country Link
US (1) US20080075784A1 (pt)
EP (1) EP1771161B1 (pt)
JP (1) JP2008507504A (pt)
AT (1) ATE464883T1 (pt)
BR (1) BRPI0513455A (pt)
CA (1) CA2574602A1 (pt)
DE (1) DE602005020796D1 (pt)
MX (1) MX2007000759A (pt)
WO (1) WO2006011051A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
CA2562585A1 (en) 2004-04-23 2005-11-10 Cydex, Inc. Dpi formulation containing sulfoalkyl ether cyclodextrin
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
SI2335707T1 (sl) 2005-10-26 2015-09-30 Cydex Pharmaceuticals, Inc. Sestavki sulfoalkil eter ciklodekstrina in metode za njihovo pripravo
US7629331B2 (en) * 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20090239942A1 (en) * 2006-09-15 2009-09-24 Cloyd James C Topiramate Compositions and Methods of Making and Using the Same
JP2009091309A (ja) * 2007-10-10 2009-04-30 Japan Organo Co Ltd バコパモニエラエキスを含有する組成物およびその製造方法ならびに飲食品
WO2009054432A1 (ja) * 2007-10-26 2009-04-30 Daiichi Sankyo Company, Limited 口腔内速崩壊性医薬組成物およびその製造方法
US20100286154A1 (en) * 2007-11-15 2010-11-11 Susanne Christine Wieland-Berghausen Antihelmintic paste
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
JP2012505222A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 肺炎症を低減するためのレボフロキサシンの吸入
FR2936952A1 (fr) * 2008-10-09 2010-04-16 Monique Bellec Administration par voie orale de medicaments et complements nutritionnels
US20100273822A1 (en) * 2009-04-22 2010-10-28 William Wayne Howard Immediate release compositions and methods for delivering drug formulations using strong acid ion exchange resins
US8545892B2 (en) 2009-06-26 2013-10-01 Nano Pharmaceutical Laboratories, Llc Sustained release beads and suspensions including the same for sustained delivery of active ingredients
US8518448B2 (en) * 2009-06-26 2013-08-27 Robert Niichel Sustained release beads and suspensions including the same for sustained delivery of active ingredients
AU2010289326B2 (en) 2009-09-04 2015-09-24 Horizon Therapeutics U.S. Holding Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US8187617B2 (en) * 2009-09-11 2012-05-29 William Wayne Howard Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
WO2011110939A2 (en) 2010-03-11 2011-09-15 Rubicon Research Private Limited Pharmaceutical compositions of substituted benzhydrylpiperazines
EP2616046B1 (en) 2010-09-13 2016-08-31 Bev-RX, Inc. Aqueous drug delivery system comprising off-flavor masking agent
CA2978593A1 (en) 2015-01-12 2016-07-21 Nano Pharmaceutical Laboratories Llc Layered sustained-release microbeads and methods of making the same
CN107288680A (zh) * 2017-07-03 2017-10-24 安徽天顺环保设备股份有限公司 一种矿用泡沫除尘剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
US5024997A (en) * 1990-06-22 1991-06-18 American Home Products Corporation Palatable ibuprofen solutions
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
DK0640344T3 (da) * 1993-08-30 1999-07-05 Medichemie Ag Ursodesoxycholsyreholdigt lægemiddel i flydende administreringsform
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
US6723358B1 (en) * 1998-03-23 2004-04-20 General Mills, Inc. Encapsulation of components into edible products
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US20030148996A1 (en) * 2000-03-31 2003-08-07 Joseph Rubinfeld Camptothecin complexes
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
RU2004123612A (ru) * 2002-01-15 2005-04-20 ЮСиБи ФАРШИМ С.А. (CH) Фармацевтическая композиция для перорального применения
MXPA04009617A (es) * 2002-04-04 2005-01-11 Pfizer Prod Inc Comprimido masticable con sabor agradable.

Also Published As

Publication number Publication date
US20080075784A1 (en) 2008-03-27
DE602005020796D1 (de) 2010-06-02
JP2008507504A (ja) 2008-03-13
EP1771161B1 (en) 2010-04-21
WO2006011051A1 (en) 2006-02-02
EP1771161A1 (en) 2007-04-11
CA2574602A1 (en) 2006-02-02
ATE464883T1 (de) 2010-05-15
MX2007000759A (es) 2007-03-28

Similar Documents

Publication Publication Date Title
BRPI0513455A (pt) formulação para mascaramento de sabor compreendendo o fármaco em uma forma de dissolução retardada e/ou ciclodextrina em uma forma de dissolução melhorada
IL231576A (en) Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
IL163894A (en) 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments
WO2005041925A3 (en) Compositions and dosage forms for enhanced absorption
IL165532A (en) History of Aryl Carbonyl, Pharmaceutical Preparations Containing Them and Their Use in the Preparation of Medicines for the Treatment of Metabolic Disorders
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
WO2006014973A3 (en) Pharmaceutical dosage forms including rasagiline
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2007009801A3 (de) Nicht-ausspuckbarer, oraler, schnell-zerfallender film für ein neuroleptikum
TW200630123A (en) Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
WO2006099169A3 (en) Novel liposome compositions
WO2004089336A3 (en) Drug delivery systems comprising an encapsulated active ingredient
BRPI0417043A (pt) composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
WO2005097076A3 (en) Low dose pharmaceutical products
IL183974A (en) Derivatives of 5h - Benzocycloheptane Tetralin and Indane, medicinal preparations containing them, and their use in the preparation of medicines
WO2013183062A3 (en) Palatable formulations of ibuprofen
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
IL201730A (en) History 1h - Benzaimidazole – 2 – Il – Profile – Methyl – Amino – Ethyl – 5 – Aryl – Bicyclo [2.2.2] Oct – 5 – Ann – 2 – All, Pharmaceutical preparations containing them and their use in the preparation of drugs
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
WO2006108692A3 (en) Dosage form for oral administration of a vitamin
CY1112637T1 (el) Παραγων για την προληψη και αγωγη των παθησεων του ηπατος περιεχοντας παραγωγο πυραζολοπυριμιδινης
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]